GSK3B and hepatocellular carcinoma: In conclusion, this study has validated the inhibitory effects of β-Sitosterol on the growth and metastasis of HCC cells in vitro; Through network pharmacology analysis, GSK3B has been identified as the target gene for β-Sitosterol.